I. Adolf Et Al. , "Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.," Asian Pacific journal of cancer prevention : APJCP , vol.20, pp.3465-3472, 2019
Adolf, I. Et Al. 2019. Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.. Asian Pacific journal of cancer prevention : APJCP , vol.20 , 3465-3472.
Adolf, I., Akan, G., Mselle, T., Dharsee, N., Namkınga, L., & Atalar, F., (2019). Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.. Asian Pacific journal of cancer prevention : APJCP , vol.20, 3465-3472.
Adolf, Ic Et Al. "Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.," Asian Pacific journal of cancer prevention : APJCP , vol.20, 3465-3472, 2019
Adolf, Ic Et Al. "Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.." Asian Pacific journal of cancer prevention : APJCP , vol.20, pp.3465-3472, 2019
Adolf, I. Et Al. (2019) . "Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.." Asian Pacific journal of cancer prevention : APJCP , vol.20, pp.3465-3472.
@article{article, author={Ic Adolf Et Al. }, title={Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.}, journal={Asian Pacific journal of cancer prevention : APJCP}, year=2019, pages={3465-3472} }